Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitis. Tomkins-Netzer O, Niederer RL, Amer R, Sar S, et al. Br J Ophthalmol 2025 Jul 11:bjo-2025-327767. doi: 10.1136/bjo-2025-327767.

Read + Share

Amedeo Smart

Independent Medical Education

Tomkins-Netzer O, Niederer RL, Amer R, Sar S, et al. Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitis. Br J Ophthalmol 2025 Jul 11:bjo-2025-327767. doi: 10.1136/bjo-2025-327767.
PMID: 40645669